Myelin and lymphocyte protein serves as a prognostic biomarker and is closely associated with the tumor microenvironment in the nephroblastoma
Open Access
- 13 January 2022
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 11 (5) , 1427-1438
Abstract
Nephroblastoma, also known as Wilms' tumor (WT), is the most common renal tumor that occurs in children. Although the efficacy of treatment has been significantly improved by a series of comprehensive treatments, some patients still have poor prognosis. Myelin and lymphocyte (MAL) protein, a highly hydrophobic integrated membrane‐bound protein, has been implicated in many tumors and is also closely linked to kidney development. However, the relationship between MAL and WT has not yet been elucidated. Therefore, we attempted to evaluate the feasibility of MAL as a promising prognosis factor for WT. The differential expression of MAL was investigated using TARGET database and was verified using the Gene Expression Omnibus database and real‐time quantitative PCR. The prognostic ability of MAL was determined using Kaplan–Meier and Cox regression analyses. Pearson correlation analysis was applied to explore the relationship between MAL expression and methylation sites. The ESTIMATE and CIBERSORT algorithms showed that MAL expression was associated with the WT tumor microenvironment. Gene Set Enrichment Analysis (GSEA) indicated that multiple signaling pathways closely associated with tumorigenesis were differentially enriched between the high‐ and low‐MAL groups. In conclusion, our study comprehensively explored the potential of MAL as a prognosis factor for WT. Meanwhile, we also demonstrated that MAL, as a prognostic factor for WT, may be closely related to the tumor microenvironment.Keywords
This publication has 53 references indexed in Scilit:
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- The role of nuclear receptors in the kidney in obesity and metabolic syndromeGenes & Nutrition, 2012
- A Wt1-Controlled Chromatin Switching Mechanism Underpins Tissue-Specific Wnt4 Activation and RepressionDevelopmental Cell, 2011
- Treatment of relapsed Wilms tumors: lessons learnedExpert Review of Anticancer Therapy, 2009
- Inactivation of the MAL Gene in Breast Cancer Is a Common Event That Predicts Benefit from Adjuvant ChemotherapyMolecular Cancer Research, 2009
- MAL promoter hypermethylation as a novel prognostic marker in gastric cancerBritish Journal of Cancer, 2008
- Fibroblasts in cancerNature Reviews Cancer, 2006
- MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathwayOncogene, 2003
- Structural and Biochemical Similarities Reveal a Family of Proteins Related to the MAL Proteolipid, a Component of Detergent-Insoluble Membrane MicrodomainsBiochemical and Biophysical Research Communications, 1997
- Cloning and characterization of MVP17: A developmentally regulated myelin protein in oligodendrocytesJournal of Neuroscience Research, 1995